Related Experiment Videos
Quinidine does not alter antipyrine metabolism
S K Bowles1, L Cardozo, D J Edwards
1College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, MI 48202.
Journal of Clinical Pharmacology
|March 1, 1990
Summary
Quinidine does not significantly affect antipyrine pharmacokinetics or metabolism, indicating cytochrome P-450db 1 is not involved in antipyrine breakdown. This study explored quinidine
Area of Science:
- Pharmacology
- Drug Metabolism
- Toxicology
Background:
- Quinidine is a known inhibitor of cytochrome P-450db 1.
- Cytochrome P-450 enzymes are crucial for drug metabolism.
- The role of P-450db 1 in antipyrine metabolism is not fully understood.
Purpose of the Study:
- To investigate quinidine's potential to inhibit other cytochrome P-450 isozymes.
- To determine if P-450db 1 plays a role in antipyrine metabolism.
- To assess the impact of quinidine pretreatment on antipyrine pharmacokinetics.
Main Methods:
- Randomized, crossover study design in six healthy male volunteers.
- Quinidine sulfate pretreatment followed by a single antipyrine dose.
- Analysis of antipyrine serum concentrations, clearance, half-life, and metabolite recovery.
Main Results:
- No significant differences in antipyrine serum concentrations, apparent oral clearance, or half-life were observed.
- Total recovery of antipyrine and its metabolites remained unchanged.
- Formation clearances for major antipyrine metabolites (norantipyrine, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine) were not altered.
Conclusions:
- Quinidine pretreatment does not significantly alter antipyrine pharmacokinetics or metabolism.
- Cytochrome P-450db 1 is unlikely to be the primary isozyme responsible for antipyrine metabolism.
- Further research may be needed to identify the specific P-450 isozymes involved in antipyrine metabolism.